Viewing Study NCT00521560

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 2:10 AM
Ignite Modification Date: 2026-02-05 @ 5:47 PM
Study NCT ID: NCT00521560
Status: COMPLETED
Last Update Posted: 2013-02-15
First Post: 2007-08-27
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: A Study of Zevalin and Simultaneous Application of BEAM High-dose Chemotherapy Followed by Autologous Stem Cell Transplantation in Refractory and Relapsed Aggressive Non-Hodgkin Lymphomas
Sponsor: Institut fuer anwendungsorientierte Forschung und klinische Studien GmbH
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Primary Non-Hodgkin-Lymphoma View
None Refractory Non-Hodgkin-Lymphoma View
None CD20+ Aggressive Non-Hodgkin's Lymphoma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None High-Dose Radio-Immuno- and Chemotherapy View
None stem cell transplantation View
None 90Y-Ibritumomab-Tiuxetan View